Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Post by jopatcloon Aug 22, 2024 8:07am
116 Views
Post# 36191356

Who’s joining us for ESC 2024 next week? 👀

Who’s joining us for ESC 2024 next week? 👀Very interesting FDA V4.0 maybe before ! ESC 2024 ?
Darios profile photo
Dario Freitas likes this
Who’s joining us for ESC 2024 next week? 
 Exciting Educational Opportunities at ESC 2024! 

What happens when experts and industry leaders join forces?
BOOM!  We did it!
+60 sessions led by expert physicians, and in collaboration with Abbott, Pfizer, Edwards Lifesciences we’ve crafted a truly exceptional educational experience.

From Echolab to Cathlab, we cover it all:

Anatomical dissection sessions for hands-on learning
Simulator sessions to practice and refine skills,
Live scanning on echo for real-time insights,
Lectures and clinical data post-processing to deepen your knowledge.

A special thank you to our partners in bringing this educational program to life.

See you in London!

ESC2024 cardiology echofirst GEHealthcare

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities